Should I buy or sell electroCore stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ECOR shares. View ECOR analyst ratings or view top-rated stocks .

What is electroCore's stock price target for 2024?

1 brokers have issued 12 month price targets for electroCore's shares. Their ECOR share price targets range from $10.00 to $10.00. On average, they expect the company's stock price to reach $10.00 in the next year. This suggests a possible upside of 77.0% from the stock's current price. View analysts price targets for ECOR or view top-rated stocks among Wall Street analysts .

How have ECOR shares performed in 2024?

electroCore's stock was trading at $5.95 on January 1st, 2024. Since then, ECOR stock has decreased by 5.0% and is now trading at $5.65. View the best growth stocks for 2024 here .

Are investors shorting electroCore?

electroCore saw a decrease in short interest in March. As of March 31st, there was short interest totaling 10,100 shares, a decrease of 40.6% from the March 15th total of 17,000 shares. Based on an average trading volume of 14,000 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.2% of the shares of the company are short sold. View electroCore's Short Interest .

When is electroCore's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our ECOR earnings forecast .

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) issued its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by $0.06. The company had revenue of $5.19 million for the quarter, compared to analyst estimates of $5.23 million. electroCore had a negative net margin of 117.49% and a negative trailing twelve-month return on equity of 201.47%. During the same period last year, the business earned ($1.22) EPS.

When did electroCore's stock split?

Shares of electroCore reverse split before market open on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO) , Heat Biologics (HTBX) , Sorrento Therapeutics (SRNE) , TherapeuticsMD (TXMD) , Vaxart (VXRT) , Bionano Genomics (BNGO) , Matinas BioPharma (MTNB) , Acasti Pharma (ACST) , Onconova Therapeutics (ONTX) and OPKO Health (OPK) .

When did electroCore IPO?

electroCore (ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

Who are electroCore's major shareholders?

electroCore's stock is owned by many different retail and institutional investors. Top institutional shareholders include International Assets Investment Management LLC (0.88%). Insiders that own company stock include Brian M Posner , Daniel S Goldberger , John P Gandolfo , Joseph P Errico, Thomas J Errico, Thomas J Errico and Trevor J Moody . View institutional ownership trends .

How do I buy shares of electroCore?

Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ECOR

electroCore (ECOR) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free ECOR Stock Alerts

$5.65

+0.01 (+0.18%)

(As of 04/19/2024 ET)

Compare

Today's Range: $5.62
▼
$6.34
50-Day Range: $5.51
▼
$7.35
52-Week Range: $3.83
▼
$8.08

Volume: 7,408 shs
Average Volume: 13,213 shs
Market Capitalization: $33.90 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.00

Get electroCore alerts:

electroCore MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 77.0% Upside
$10.00 Price Target
Short Interest: Healthy
0.22% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.00
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.59) to ($0.33) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.02 out of 5 stars

Medical Sector

561st out of 911 stocks

Electromedical Equipment Industry

7th out of 19 stocks

3.5

Analyst's Opinion

Consensus Rating
electroCore has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
electroCore has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.22% of the float of electroCore has been sold short.
Short Interest Ratio / Days to Cover
electroCore has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in electroCore has recently decreased by 40.59%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
electroCore does not currently pay a dividend.
Dividend Growth
electroCore does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ECOR.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 2 news articles for electroCore this week, compared to 1 article on an average week.
Search Interest
5 people have searched for ECOR on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added electroCore to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, electroCore insiders have not sold or bought any company stock.
Percentage Held by Insiders
13.14% of the stock of electroCore is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 26.74% of the stock of electroCore is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for electroCore are expected to grow in the coming year, from ($1.59) to ($0.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of electroCore is -1.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of electroCore is -1.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
electroCore has a P/B Ratio of 4.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About electroCore Stock (NASDAQ:ECOR)

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

ECOR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ECOR Stock News Headlines

April 18, 2024 | finance.yahoo.com

electroCore, Inc. (ECOR) Interactive Stock Chart - Yahoo Finance

April 18, 2024 | finance.yahoo.com

electroCore, Inc. (ECOR)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 8, 2024 | globenewswire.com

electroCore Announces the Launch of Truvaga Plus® for General Wellness

April 2, 2024 | globenewswire.com

electroCore Expands Intellectual Property Portfolio

March 16, 2024 | finance.yahoo.com

electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript

March 15, 2024 | seekingalpha.com

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

March 15, 2024 | markets.businessinsider.com

Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 14, 2024 | finanznachrichten.de

electroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

March 14, 2024 | finance.yahoo.com

Q4 2023 electroCore, Inc. Earnings Call

March 14, 2024 | finance.yahoo.com

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

March 13, 2024 | globenewswire.com

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

March 12, 2024 | msn.com

ElectroCore Q4 2023 Earnings Preview

March 12, 2024 | markets.businessinsider.com

Here's what to expect from electroCore's earnings

March 12, 2024 | globenewswire.com

electroCore to Participate in Upcoming Investor Conferences

March 5, 2024 | globenewswire.com

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

February 19, 2024 | lse.co.uk

Ecora Res. Share Chat

February 15, 2024 | morningstar.com

Ecora Resources PLC ECOR

January 12, 2024 | finance.yahoo.com

electroCore, Inc. (ECOR) Stock Historical Prices & Data - Yahoo Finance

January 11, 2024 | finanznachrichten.de

electroCore, Inc.: electroCore Expands Intellectual Property Portfolio

December 26, 2023 | finance.yahoo.com

electroCore Expands Intellectual Property Portfolio

December 12, 2023 | finance.yahoo.com

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

November 15, 2023 | finance.yahoo.com

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

November 11, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Technology Stocks: Unity Software (U) and Electrocore (ECOR)

November 9, 2023 | finance.yahoo.com

electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript

November 8, 2023 | msn.com

ElectroCore GAAP EPS of -$0.68 beats by $0.02, revenue of $4.5M beats by $0.72M

See More Headlines

Receive ECOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for electroCore and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/13/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:ECOR
CUSIP: N/A
CIK: 1560258
Web: www.electrocore.com
Phone: (973) 290-0097
Fax: N/A
Employees: 68
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $10.00
High Stock Price Target: $10.00
Low Stock Price Target: $10.00
Potential Upside/Downside: +73.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.56)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,830,000.00
Net Margins: -117.49%
Pretax Margin: -118.65%
Return on Equity: -201.47%
Return on Assets: -109.61%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.76
Quick Ratio: 1.49

Sales & Book Value

Annual Sales: $16.03 million
Price / Sales: 2.16
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.24 per share
Price / Book: 4.65

Miscellaneous

Outstanding Shares: 6,000,000
Free Float: 5,214,000
Market Cap: $34.62 million
Optionable: Not Optionable
Beta: 0.91

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Daniel S. Goldberger (Age 65)
CEO & Director
Comp: $1.05M
Dr. Thomas J. Errico M.D. (Age 72)
Founder, Independent Director & Principal Investor
Comp: $58.12k
Mr. Brian M. Posner CPA (Age 62)
MBA., CFO & Corporate Secretary
Comp: $599.88k
Mr. Michael Romaniw (Age 67)
Executive Vice President of Systems & Operations
Mr. Mitch Deshon
Vice President of Global Sales & Business Development
Ms. Carrie Kochek
Senior Director of Human Resources
Dr. Peter S. Staats M.B.A. (Age 60)
M.D., Chief Medical Officer
Comp: $238.41k
Mr. Joshua S. Lev
Chief Strategy Officer
Mr. Manuel A. Marques (Age 51)
Senior Vice President of Operations
Ms. Amanda Yanuklis
Chief of Staff

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ECOR Stock Analysis - Frequently Asked Questions

Should I buy or sell electroCore stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ECOR shares.
View ECOR analyst ratings or view top-rated stocks.
What is electroCore's stock price target for 2024?: 1 brokers have issued 12 month price targets for electroCore's shares. Their ECOR share price targets range from $10.00 to $10.00. On average, they expect the company's stock price to reach $10.00 in the next year. This suggests a possible upside of 77.0% from the stock's current price.
View analysts price targets for ECOR or view top-rated stocks among Wall Street analysts.
How have ECOR shares performed in 2024?: electroCore's stock was trading at $5.95 on January 1st, 2024. Since then, ECOR stock has decreased by 5.0% and is now trading at $5.65.
View the best growth stocks for 2024 here.
Are investors shorting electroCore?: electroCore saw a decrease in short interest in March. As of March 31st, there was short interest totaling 10,100 shares, a decrease of 40.6% from the March 15th total of 17,000 shares. Based on an average trading volume of 14,000 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.2% of the shares of the company are short sold.
View electroCore's Short Interest.
When is electroCore's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ECOR earnings forecast.
How were electroCore's earnings last quarter?: electroCore, Inc. (NASDAQ:ECOR) issued its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by $0.06. The company had revenue of $5.19 million for the quarter, compared to analyst estimates of $5.23 million. electroCore had a negative net margin of 117.49% and a negative trailing twelve-month return on equity of 201.47%. During the same period last year, the business earned ($1.22) EPS.

When did electroCore's stock split?: Shares of electroCore reverse split before market open on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What other stocks do shareholders of electroCore own?: Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK).
When did electroCore IPO?: electroCore (ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.
Who are electroCore's major shareholders?: electroCore's stock is owned by many different retail and institutional investors. Top institutional shareholders include International Assets Investment Management LLC (0.88%). Insiders that own company stock include Brian M Posner, Daniel S Goldberger, John P Gandolfo, Joseph P Errico, Thomas J Errico, Thomas J Errico and Trevor J Moody.
View institutional ownership trends.
How do I buy shares of electroCore?: Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ECOR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial